Background: Acute exacerbation (AE) is a common cause of rapid deterioration and high mortality in idiopathic pulmonary fibrosis (IPF) patients. Osteopontin (OPN) plays an important role in IPF, but the studies about serum OPN in AE-IPF are unclear. We aimed to investigate whether OPN had a potential prognostic value in acute exacerbation and mortality in IPF.
Methods: Thirty-two patients with AE-IPF, 39 with S-IPF, and 20 healthy controls were included. Serum OPN and KL-6 levels were compared between AE-IPF and S-IPF. Logistic regression analysis was applied to identify the predicted value of OPN for AE. Kaplan-Meier curves were used to display survival, and Cox proportional hazards regression was used to identify risk for mortality.
Results: In AE-IPF patients, serum OPN levels were significantly higher than in S-IPF subjects ( < 0.001) or healthy controls ( < 0.001) or healthy controls ( < 0.001) or healthy controls ( < 0.001) or healthy controls ( < 0.001) or healthy controls ( < 0.001) or healthy controls ( < 0.001) or healthy controls ( < 0.001) or healthy controls ( < 0.001) or healthy controls ( < 0.001) or healthy controls (.
Conclusion: Elevated OPN could be a potential serum predictor for AE status and survival in IPF patients.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035537 | PMC |
http://dx.doi.org/10.1155/2020/3424208 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!